Nociceptin/OrphaninFQ Receptor Modulates the Maturation of Adult-Born Neurons in the Mouse Dentate Gyrus Under Physiological Conditions and in a Chronic Stress Model
- PMID: 40415055
- DOI: 10.1007/s12035-025-05062-6
Nociceptin/OrphaninFQ Receptor Modulates the Maturation of Adult-Born Neurons in the Mouse Dentate Gyrus Under Physiological Conditions and in a Chronic Stress Model
Abstract
Neurogenesis persists in the adult dentate gyrus (DG) of the hippocampus, playing a critical role in memory and stress adaptation. Dysregulation of this process is implicated in cognitive deficits and depressive behaviors induced by chronic stress, while classical antidepressants are known to enhance neurogenesis. The Nociceptin/Orphanin FQ (N/OFQ) system, comprising N/OFQ and its NOP receptor, modulates memory and the stress response, yet its role in adult neurogenesis remains underexplored. Here, we investigated the impact of N/OFQ signaling on neurogenesis in the mouse DG using genetic and pharmacological approaches under basal and chronic stress conditions. In constitutive NOP receptor knockout (KO) mice, adult neurogenesis was only mildly altered, with subtle changes in neuronal maturation. However, spine density in 4-week-old adult-born DG neurons increased following conditional NOP Receptor KO in the DG. The increase was specific to stubby and thin spines, while mature mushroom spine density decreased. When NOP KO was restricted to newly born neurons, no significant differences were observed in spine density suggesting that the absence of NOP receptors in mature DG neurons influences the local environment to regulate spinogenesis in adult-born neurons indirectly. Finally, chronic corticosterone exposure impaired spinogenesis in immature neurons, and this was mitigated by systemic administration of a NOP antagonist. Our findings suggest that N/OFQ signaling indirectly regulates the maturation and connectivity of adult-born neurons through modulation of local and distal inputs. This regulation may contribute to the antidepressant and pro-cognitive effects of NOP receptor antagonists.
Keywords: Adult neurogenesis; Chronic stress; Dendritic spine; Dentate gyrus; NOP receptor; Nociceptin/Orphanin FQ (N/OFQ).
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics Approval: The animal protocol was approved by the local Ethics Committee and the French Ministry of Education and Research (APAFIS#27219–2020091610141233). All experiments complied with the European guidelines for the care of laboratory animals (European Union Directive 2010/63/EU) and French or Italian regulations. Competing interests: The authors declare no competing interests.
Similar articles
-
The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.Pharmacol Ther. 2014 Mar;141(3):283-99. doi: 10.1016/j.pharmthera.2013.10.011. Epub 2013 Nov 1. Pharmacol Ther. 2014. PMID: 24189487 Free PMC article. Review.
-
Nociceptin/orphanin FQ receptor antagonists as innovative antidepressant drugs.Pharmacol Ther. 2013 Oct;140(1):10-25. doi: 10.1016/j.pharmthera.2013.05.008. Epub 2013 May 24. Pharmacol Ther. 2013. PMID: 23711793 Review.
-
Targeting Nociceptin/Orphanin FQ receptor to rescue cognitive symptoms in a mouse neuroendocrine model of chronic stress.Mol Psychiatry. 2024 Mar;29(3):718-729. doi: 10.1038/s41380-023-02363-x. Epub 2023 Dec 20. Mol Psychiatry. 2024. PMID: 38123728
-
Sex Differences in Nociceptin/Orphanin FQ Peptide Receptor-Mediated Pain and Anxiety Symptoms in a Preclinical Model of Post-traumatic Stress Disorder.Front Psychiatry. 2019 Jan 8;9:731. doi: 10.3389/fpsyt.2018.00731. eCollection 2018. Front Psychiatry. 2019. PMID: 30670988 Free PMC article.
-
Neuropeptide orphanin FQ inhibits dendritic morphogenesis through activation of RhoA.Dev Neurobiol. 2013 Oct;73(10):769-84. doi: 10.1002/dneu.22101. Epub 2013 Aug 20. Dev Neurobiol. 2013. PMID: 23821558
References
-
- Toll L, Bruchas MR, Calo G et al (2016) Nociceptin/Orphanin FQ receptor structure, signaling, ligands, functions, and interactions with opioid systems. Pharmacol Rev 68:419–457. https://doi.org/10.1124/pr.114.009209 - DOI - PubMed - PMC
-
- Toll L, Cippitelli A, Ozawa A (2021) The NOP receptor system in neurological and psychiatric disorders: discrepancies, peculiarities and clinical progress in developing targeted therapies. CNS Drugs 35:591–607. https://doi.org/10.1007/s40263-021-00821-0 - DOI - PubMed - PMC
-
- Zaveri NT (2016) Nociceptin opioid receptor (NOP) as a therapeutic target: progress in translation from preclinical research to clinical utility. J Med Chem 59:7011–7028. https://doi.org/10.1021/acs.jmedchem.5b01499 - DOI - PubMed - PMC
-
- Gavioli EC, Holanda VAD, Calo G, Ruzza C (2021) Nociceptin/orphanin FQ receptor system blockade as an innovative strategy for increasing resilience to stress. Peptides 141:170548. https://doi.org/10.1016/j.peptides.2021.170548 - DOI - PubMed
-
- Ubaldi M, Cannella N, Borruto AM, et al (2021) Role of nociceptin/orphanin FQ-NOP receptor system in the regulation of stress-related disorders. Int J Mol Sci 22:. https://doi.org/10.3390/ijms222312956
LinkOut - more resources
Full Text Sources
Research Materials